Literature DB >> 20881126

Transgenic mice with chronic NGF deprivation and Alzheimer's disease-like pathology display hippocampal region-specific impairments in short- and long-term plasticities.

Gry Houeland1, Armando Romani, Cristina Marchetti, Gianluca Amato, Simona Capsoni, Antonino Cattaneo, Hélène Marie.   

Abstract

The etiology of Alzheimer's disease (AD) remains elusive. The "amyloid" hypothesis states that toxic action of accumulated β-amyloid peptide (Aβ) on synaptic function causes AD cognitive decline. This hypothesis is supported by analysis of familial AD (FAD)-based transgenic mouse models, where altered amyloid precursor protein (APP) processing leads to Aβ accumulation correlating with hippocampal-dependent memory deficits. Some studies report prominent dentate gyrus (DG) glutamatergic plasticity alterations in these mice, while CA1 plasticity remains relatively unaffected. The "neurotrophic unbalance" hypothesis, on the other hand, states that AD-related loss of cholinergic signaling and altered APP processing are due to alterations in nerve growth factor (NGF) trophic support. This hypothesis is supported by analysis of the AD11 mouse, which exhibits chronic NGF deprivation during adulthood and displays AD-like pathology, including Aβ accumulation and hippocampal-dependent memory deficits. In this study, we analyzed CA1 and DG glutamatergic plasticity in AD11 mice to evaluate whether these mice also share with FAD models a common phenotype in hippocampal synaptic dysfunction. We report that AD11 mice display age-dependent short- and long-term DG plasticity deficits, while CA1 plasticity remains relatively spared. We also report that both structures exhibit enhanced glutamatergic transmission under lower, yet physiological, neurotransmitter release conditions, a defect that should be considered when further evaluating hippocampal synaptic deficits underlying AD pathology. We conclude that severe deficits in DG plasticity represent another common denominator between these two etiologically different types of AD mouse models, independent of the initial insult (overexpression of FAD mutation or NGF deprivation).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20881126      PMCID: PMC6633528          DOI: 10.1523/JNEUROSCI.0457-10.2010

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  20 in total

1.  Age-dependent accumulation of soluble amyloid beta (Abeta) oligomers reverses the neuroprotective effect of soluble amyloid precursor protein-alpha (sAPP(alpha)) by modulating phosphatidylinositol 3-kinase (PI3K)/Akt-GSK-3beta pathway in Alzheimer mouse model.

Authors:  Sebastian Jimenez; Manuel Torres; Marisa Vizuete; Raquel Sanchez-Varo; Elisabeth Sanchez-Mejias; Laura Trujillo-Estrada; Irene Carmona-Cuenca; Cristina Caballero; Diego Ruano; Antonia Gutierrez; Javier Vitorica
Journal:  J Biol Chem       Date:  2011-04-01       Impact factor: 5.157

2.  Gender differences in neurotrophin and glutamate receptor expression in cholinergic nucleus basalis neurons during the progression of Alzheimer's disease.

Authors:  Scott E Counts; Shaoli Che; Stephen D Ginsberg; Elliott J Mufson
Journal:  J Chem Neuroanat       Date:  2011-03-17       Impact factor: 3.052

3.  Hsp90 chaperone inhibitor 17-AAG attenuates Aβ-induced synaptic toxicity and memory impairment.

Authors:  Yaomin Chen; Bin Wang; Dan Liu; Jing Jing Li; Yueqiang Xue; Kazuko Sakata; Ling-qiang Zhu; Scott A Heldt; Huaxi Xu; Francesca-Fang Liao
Journal:  J Neurosci       Date:  2014-02-12       Impact factor: 6.167

4.  Cognitive enhancing treatment with a PPARγ agonist normalizes dentate granule cell presynaptic function in Tg2576 APP mice.

Authors:  Miroslav N Nenov; Fernanda Laezza; Sigmund J Haidacher; Yingxin Zhao; Rovshan G Sadygov; Jonathan M Starkey; Heidi Spratt; Bruce A Luxon; Kelly T Dineley; Larry Denner
Journal:  J Neurosci       Date:  2014-01-15       Impact factor: 6.167

5.  Deficits in synaptic function occur at medial perforant path-dentate granule cell synapses prior to Schaffer collateral-CA1 pyramidal cell synapses in the novel TgF344-Alzheimer's Disease Rat Model.

Authors:  Lindsey A Smith; Lori L McMahon
Journal:  Neurobiol Dis       Date:  2017-12-01       Impact factor: 5.996

Review 6.  Combination of Aβ clearance and neurotrophic factors as a potential treatment for Alzheimer's disease.

Authors:  Lian-Feng Lin; Min-Jing Liao; Xiao-Yan Xue; Wei Zhang; Li Yan; Liang Cai; Xiao-Wen Zhou; Xing Zhou; Huan-Min Luo
Journal:  Neurosci Bull       Date:  2012-11-21       Impact factor: 5.203

7.  Intranasal "painless" human Nerve Growth Factor [corrected] slows amyloid neurodegeneration and prevents memory deficits in App X PS1 mice.

Authors:  Simona Capsoni; Sara Marinelli; Marcello Ceci; Domenico Vignone; Gianluca Amato; Francesca Malerba; Francesca Paoletti; Giovanni Meli; Alessandro Viegi; Flaminia Pavone; Antonino Cattaneo
Journal:  PLoS One       Date:  2012-05-30       Impact factor: 3.240

Review 8.  Targeting synaptic dysfunction in Alzheimer's disease therapy.

Authors:  Robert Nisticò; Marco Pignatelli; Sonia Piccinin; Nicola B Mercuri; Graham Collingridge
Journal:  Mol Neurobiol       Date:  2012-08-23       Impact factor: 5.590

9.  The Adaptor Protein CD2AP Is a Coordinator of Neurotrophin Signaling-Mediated Axon Arbor Plasticity.

Authors:  Benjamin J Harrison; Gayathri Venkat; James L Lamb; Tom H Hutson; Cassa Drury; Kristofer K Rau; Mary Barlett Bunge; Lorne M Mendell; Fred H Gage; Richard D Johnson; Caitlin E Hill; Eric C Rouchka; Lawrence D F Moon; Jeffrey C Petruska
Journal:  J Neurosci       Date:  2016-04-13       Impact factor: 6.167

10.  η-Secretase processing of APP inhibits neuronal activity in the hippocampus.

Authors:  Michael Willem; Sabina Tahirovic; Marc Aurel Busche; Saak V Ovsepian; Magda Chafai; Scherazad Kootar; Daniel Hornburg; Lewis D B Evans; Steven Moore; Anna Daria; Heike Hampel; Veronika Müller; Camilla Giudici; Brigitte Nuscher; Andrea Wenninger-Weinzierl; Elisabeth Kremmer; Michael T Heneka; Dietmar R Thal; Vilmantas Giedraitis; Lars Lannfelt; Ulrike Müller; Frederick J Livesey; Felix Meissner; Jochen Herms; Arthur Konnerth; Hélène Marie; Christian Haass
Journal:  Nature       Date:  2015-08-31       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.